A new initiative has been launched in the UAE to support low-income expatriates battling cancer and multiple sclerosis.
They will be provided with medication as part of the Ministry of Health and Prevention's (MOHAP) new agreement with the pharmaceutical firm Merck Serono, and Manzil Healthcare Services.
The programme will benefit patients diagnosed with colorectal, head and neck, and urothelial cancer, as well as multiple sclerosis.
It aims to support those who don't have medical insurance and those with partial coverage.
"The initiative is one of a series of memoranda of understanding signed by the ministry to improve the services provided to low-income patients and secure their access to high-quality medicines," said Dr. Amin Hussein Al Amiri, Assistant Undersecretary for the Health Regulation Sector at MOHAP.
"It will help doctors follow the best practices in the treatment plan, and enable patients to follow up and complete their treatment plan," he added.
UAE air defences intercept two drones on Sunday, no injuries
Dubai Police launches new 'National Inspector' security role at airports
Abdullah bin Zayed condemns IRGC-linked cell in Bahrain
RTA opens Dubai's first Smart Bus Station at Mall of the Emirates
H.H. Sheikh Mohammed launches humanitarian programme tackling river blindness
Al Rashidiya Police Station records 99.05 per cent safety perception rate
UAE President, VPs congratulate Hungarian PM on taking oath
Abdullah bin Zayed, Estonian FM discuss bilateral relations
